DoubleLine ETF Adviser »

Vertex Pharmaceuticals Incorporated shares owned by DoubleLine ETF Adviser

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by DoubleLine ETF Adviser from 13F filings

Historical chart of DoubleLine ETF Adviser investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by DoubleLine ETF Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by DoubleLine ETF Adviser

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 3.2k 446.54

More positions owned by DoubleLine ETF Adviser

Amazon (AMZN)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Welltower Inc Com reit (WELL)
Prologis (PLD)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Netflix (NFLX)
Verizon Communications (VZ)
Home Depot (HD)
At&t (T)
Merck & Co (MRK)

View all positions for DoubleLine ETF Adviser

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Alliancebernstein
Wellington Management Company
Victory Capital Management
Morgan Stanley
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated